Ensign Peak Advisors
ANIP icon

Ensign Peak Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

Ensign Peak Advisors’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$159K Hold
1,917
– – ﹤0.01% 1479
2026
Q1 		$147K Hold
1,917
– – ﹤0.01% 1453
2025
Q4 		$151K Sell
1,917
-4,200
-69% -$364K ﹤0.01% 1434
2025
Q3 		$560K Sell
6,117
-4,550
-43% -$371K ﹤0.01% 1334
2025
Q2 		$696K Sell
10,667
-1,550
-13% -$101K ﹤0.01% 1440
2025
Q1 		$818K Hold
12,217
– – ﹤0.01% 1361
2024
Q4 		$675K Hold
12,217
– – ﹤0.01% 1510
2024
Q3 		$729K Hold
12,217
– – ﹤0.01% 1489
2024
Q2 		$778K Hold
12,217
– – ﹤0.01% 1440
2024
Q1 		$845K Sell
12,217
-616
-5% -$37.2K ﹤0.01% 1427
2023
Q4 		$708K Hold
12,833
– – ﹤0.01% 1559
2023
Q3 		$745K Hold
12,833
– – ﹤0.01% 1413
2023
Q2 		$691K Buy
12,833
+800
+7% +$35.5K ﹤0.01% 1509
2023
Q1 		$478K Buy
12,033
+500
+4% +$21.1K ﹤0.01% 1652
2022
Q4 		$464K Buy
11,533
+4,300
+59% +$162K ﹤0.01% 1635
2022
Q3 		$232K Sell
7,233
-560
-7% -$19.2K ﹤0.01% 1815
2022
Q2 		$231K Hold
7,793
– – ﹤0.01% 1749
2022
Q1 		$219K Hold
7,793
– – ﹤0.01% 1852
2021
Q4 		$359K Sell
7,793
-5,390
-41% -$232K ﹤0.01% 1748
2021
Q3 		$433K Hold
13,183
– – ﹤0.01% 1651
2021
Q2 		$462K Hold
13,183
– – ﹤0.01% 1607
2021
Q1 		$476K Hold
13,183
– – ﹤0.01% 1598
2020
Q4 		$383K Hold
13,183
– – ﹤0.01% 1644
2020
Q3 		$372K Hold
13,183
– – ﹤0.01% 1594
2020
Q2 		$426K Hold
13,183
– – ﹤0.01% 1489
2020
Q1 		$537K Hold
13,183
– – ﹤0.01% 1378
2019
Q4 		$813K Buy
+13,183
New +$873K ﹤0.01% 1402

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ensign Peak Advisors's ANIP Position: Q2 2026 in Review

Ensign Peak Advisors held its ANI Pharmaceuticals (ANIP) position steady in Q2 2026 at 1,917 shares worth $159K. The position accounts for ﹤0.01% of the portfolio, ranked #1479.

Ensign Peak Advisors first reported a position in ANIP in Q4 2019 and has held it in 27 quarters since. The position peaked at $845K in Q1 2024. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Ensign Peak Advisors held 1,917 shares of ANI Pharmaceuticals worth $159K as of Q2 2026.
  • Ensign Peak Advisors left its ANI Pharmaceuticals share count unchanged in Q2 2026.
  • ANI Pharmaceuticals made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #1479 holding.
  • Ensign Peak Advisors first reported a position in ANI Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
  • Ensign Peak Advisors's ANI Pharmaceuticals position peaked at $845K in Q1 2024.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.